Published On: Wed, Sep 13th, 2017

Reviewing Individual Broker Targets Of TriVascular Technologies, Inc. (NASDAQ:TRIV)


Recently stock market analysts have updated their consensus ratings on shares of TriVascular Technologies, Inc. (NASDAQ:TRIV).

Most recent broker ratings

11/23/2015 – TriVascular Technologies, Inc. was downgraded to “neutral” by analysts at BTIG Research.

08/10/2015 – TriVascular Technologies, Inc. had its “hold” rating reiterated by analysts at Credit Suisse. They now have a USD 8 price target on the stock.

08/05/2015 – TriVascular Technologies, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 13 price target on the stock.

05/08/2015 – TriVascular Technologies, Inc. was downgraded to “sell” by analysts at Zacks.

05/06/2015 – TriVascular Technologies, Inc. had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 11 price target on the stock.

05/06/2015 – TriVascular Technologies, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 9 price target on the stock.

TriVascular Technologies, Inc. has a 50 day moving average of 6.49 and a 200 day moving average of 6.07.It has a 52-week low of 3.98 and a 52-week high of 11.49.

The share price of the company (NASDAQ:TRIV) was up +0.00% during the last trading session, with a high of 0.00 and the volume of TriVascular Technologies, Inc. shares traded was 0.